지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.10
- 수록면
- 474 - 476 (3page)
- DOI
- 10.5021/ad.2021.33.5.474
이용수
초록· 키워드
오류제보하기
등록된 정보가 없습니다.
목차
등록된 정보가 없습니다.
참고문헌 (5)
참고문헌 신청
Birol A / 2006 / Increased tumor necrosis factor alpha(TNF-alpha)and interleukin 1 alpha(IL1-alpha)levels in the lesional skin of patients with nonsegmental vitiligo / Int J Dermatol 45:992~993
Martínez-Esparza M / 1998 / Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16/F10 mouse melanoma cells / Eur J Biochem 255:139~146
Webb KC / 2015 / Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo / Br J Dermatol 173:641~650
정준민 / 2015 / Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response? / Annals of Dermatology 27(5):620~621
Maruthappu T / 2013 / Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab / Dermatol Ther 26:370~372
Martínez-Esparza M / 1998 / Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16/F10 mouse melanoma cells / Eur J Biochem 255:139~146
Webb KC / 2015 / Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo / Br J Dermatol 173:641~650
정준민 / 2015 / Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response? / Annals of Dermatology 27(5):620~621
Maruthappu T / 2013 / Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab / Dermatol Ther 26:370~372
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Development of Vitiligo during Treatment with Adalimumab: A Plausible or Paradoxical Response?
Annals of Dermatology
2015 .01
-
안면 백반증 치료 평가를 위한 딥러닝 기반 자동화 분석 시스템 개발
의공학회지
2024 .04
-
Prevalence of Vitiligo and Associated Comorbidities in Korea
Yonsei Medical Journal
2015 .01
-
Adalimumab Treatment in Pediatric-Onset Crohn’s Disease Patients after Infliximab Failure: A Single Center Study
Pediatric Gastroenterology, Hepatology & Nutrition
2016 .01
-
Long-term safety and efficacy of adalimumab for intestinal Behçet’s disease in the open label study following a phase 3 clinical trial
Intestinal research
2017 .01
-
Pulmonary Sarcoidosis Induced by Adalimumab: A Case Report and Literature Review
Yonsei Medical Journal
2016 .01
-
A Case of Segmental Vitiligo Along Blaschko’s Lines
Annals of Dermatology
2018 .01
-
Evaluation of Advanced Oxidation Protein Products, Prooxidant-Antioxidant Balance, and Total Antioxidant Capacity in Untreated Vitiligo Patients
Annals of Dermatology
2015 .01
-
Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
Gut and Liver
2021 .01
-
Adalimumab 치료 후 발생한 Myopathy 1예
대한건선학회지
2019 .01
-
Synchronous Onset of Symmetrically Associated Extragenital Lichen Sclerosus and Vitiligo on both Breasts and the Vulva
Annals of Dermatology
2015 .01
-
Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
Gut and Liver
2016 .01
-
Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?
Gut and Liver
2022 .01
-
Atypical Pattern of Choroidal Hypopigmentation with Cutaneous Vitiligo
Korean Journal of Ophthalmology
2019 .01
-
A Type II Segmental Vitiligo Developed under Infliximab Treatment for Ulcerative Colitis
Annals of Dermatology
2017 .01
-
Being healthy : Feeling healthy
셀메드
2018 .02
-
Progression of Pre-Existing Vitiligo during Secukinumab Treatment for Psoriasis
Annals of Dermatology
2023 .05
-
Up-and-Coming Drugs for the Treatment of Vitiligo
Annals of Dermatology
2024 .08
-
Could adalimumab be used safely and effectively in intestinal Behçet’s disease refractory to conventional therapy?
Intestinal research
2017 .01
-
Adalimumab or infliximab: which is better for perianal fistula in Crohn’s disease?
Intestinal research
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0